Your browser doesn't support javascript.
loading
Timing and safety of hip fracture surgery in patients on direct-acting oral anticoagulants.
Anazor, Fitzgerald; Kulkarni, Avadhut; Barnard, Karen; Lancaster, Sarah; Pollard, Tom.
Afiliação
  • Anazor F; Royal Berkshire Hospital, Reading, United Kingdom.
  • Kulkarni A; Nottingham University NHS Foundation Trust, United Kingdom.
  • Barnard K; Royal Berkshire Hospital, Reading, United Kingdom.
  • Lancaster S; Royal Berkshire Hospital, Reading, United Kingdom.
  • Pollard T; Royal Berkshire Hospital, Reading, United Kingdom.
J Clin Orthop Trauma ; 36: 102080, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36465496
ABSTRACT

Background:

Many geriatric patients presenting for emergency hip fracture surgery are on direct oral anticoagulants (DOACs) most of which are not easily reversible. A safe policy was required to reduce delays to surgery. Prior to institution of our hospital's protocol in January 2021, most of these patients had surgery after 48 h following the last dose of DOAC due to concerns about increased perioperative blood loss.

Methods:

This was a prospective closed loop audit of the protocol-surgery within 24 h from last dose of DOAC (if creatinine clearance >50 ml/min) with administration of 1-g of tranexamic acid at anesthesia induction. 131 eligible patients (DOAC, n = 22; no anticoagulation, n = 109) between January-June 2021 who had emergency hip fracture surgery were identified. Primary outcome measures were peri-operative blood loss, transfusion requirements and policy compliance. Secondary outcome measures were 30-day mortality, thrombotic complications and wound bleeding.

Results:

Compliance with surgical timing and tranexamic acid administration were 55% and 81% respectively after the second audit cycle. The mean estimated blood loss (EBL) in the DOAC group versus the non-anticoagulated control group was 500 ml and 330 ml respectively. The difference between these groups was statistically significant at an alpha level of 5% (P = 0.0115, 95% CI 38.48-299.16). The difference for intra-operative (RR 3.43; 95% CI 1.68-7.01) and post-operative blood transfusion (RR 2.10; 95% CI 1.23-3.58) for the 2 groups was also statistically significant. However, there was no case of massive blood transfusion in both groups. The DOAC group had a lower risk for 30-day mortality (RR 0.71; 95% CI 0.09-5.46). There was no major thrombotic complication in the DOAC group.

Conclusion:

This audit has shown that this protocol is safe although clinicians should anticipate some degree of increased intra-operative blood loss. We will recommend continuation of this policy with sustained safety monitoring in order to reduce delays to surgery.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Orthop Trauma Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Orthop Trauma Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido